Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Single Arm Adaptive-design Study to Evaluate the Survivorship of the Maxx Orthopedics' PCK System in Revision Cases

NCT03312088 is registered in ClinicalTrials.gov with Maxx Orthopedics Inc as lead sponsor.

NCT NCT03312088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03312088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Single Arm Adaptive-design Study to Evaluate the Survivorship of the Maxx Orthopedics' PCK System in Revision Cases
Lead sponsor
Maxx Orthopedics Inc
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
February 28, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aseptic loosening, bone loss, infection, mcl - medial collateral ligament rupture of the knee, periprosthetic fractures